<?xml version="1.0" encoding="UTF-8"?>
<p id="Par13">The following eight cohorts were utilized in this study; Biofind (
 <ext-link ext-link-type="uri" xlink:href="https://biofind.loni.usc.edu/" xmlns:xlink="http://www.w3.org/1999/xlink">https://biofind.loni.usc.edu/</ext-link>), NABEC [
 <xref ref-type="bibr" rid="CR11">11</xref>], LNG Path confirmed, PDBP (
 <ext-link ext-link-type="uri" xlink:href="https://pdbp.ninds.nih.gov/" xmlns:xlink="http://www.w3.org/1999/xlink">https://pdbp.ninds.nih.gov/</ext-link>), NIH PD CLINIC, PPMI (
 <ext-link ext-link-type="uri" xlink:href="https://www.ppmi-info.org/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.ppmi-info.org/</ext-link>), WELLDERLY and UKBEC. Clinical and demographic characteristics of the cohorts under study are summarised in Supplementary TableÂ 2, online resource. Participants included sporadic PD cases clinically diagnosed by experienced neurologists. PD cases met criteria defined by the UK PD Society Brain Bank. This included 2101 cases and 2230 controls. All individuals were of European descent and were not age- or gender-matched.
</p>
